Insertion sequence transposition determines imipenem resistance in Acinetobacter baumannii.

Han-Yueh Kuo,Kai-Chih Chang,Chih-Chin Liu,Chuan Yi Tang,Jhih-Hua Peng,Chia-Wei Lu,Chi-Chao Tu,Ming-Li Liou
DOI: https://doi.org/10.1089/mdr.2014.0004
2014-01-01
Microbial Drug Resistance
Abstract:This study employed genomewide analysis to investigate potential resistance mechanisms in Acinetobacter baumannii following imipenem exposure. Imipenem-selected mutants were generated from the imipenem-susceptible strain ATCC 17978 by multistep selection resistance. Antibiotic susceptibilities were examined, and the selected mutants originated from the ATCC 17978 strain were confirmed by pulsed-field gel electrophoresis. The genomic sequence of a resistant mutant was analyzed using a next-generation sequencing platform, and genetic recombination was further confirmed by PCR. The result showed that phenotypic resistance was observed with carbapenem upon exposure to various concentrations of imipenem. Genomewide analysis showed that ISAba1 transposition was initiated by imipenem exposure at concentrations up to 0.5 mg/L. Transposition of ISAba1 upstream of bla(OXA-95) was detected in all the selected mutants. The expression of bla(OXA-95) was further analyzed by quantitative PCR, and the results demonstrated that a 200-fold increase in gene expression was required for resistance to imipenem. This study concluded that imipenem exposure at a concentration of 0.5 mg/L mediated the transposition of ISAba1 upstream of the bla(OXA-95) gene and resulted in the overexpression of bla(OXA-95) gene, which may play a major role in the resistance to imipenem in A. baumannii.
What problem does this paper attempt to address?